Table 1

Percentage of fibroblasts and contaminating cells in primary cultures of RA and OA synovial fibroblast cells at various passages

Passage

Cell type

% positive cells (Mean ± SEM)*


RA SF

OA SF


First

Fibroblast (Prolyl-4-hydroxylase +)1

75 ± 8.0

68 ± 5.0

Monocyte/macrophage (CD14+)2

15 ± 2.0

21 ± 3.5

T-cells (CD3+)3

0.8 ± 0.2

1.2 ± 0.3

B-cells (CD20+)4

0.9 ± 0.3

0.8 ± 0.2

Third

Fibroblast (Prolyl-4-hydroxylase +)

99 ± 0.5

98.5 ± 0.6

Monocyte/macrophage (CD14+)

0.8 ± 0.2

0.6 ± 0.1

T-cells (CD3+)

0.5 ± 0.1

0.8 ± 0.2

B-cells (CD20+)

0.6 ± 0.2

0.5 ± 0.1

Fourth

Fibroblast (Prolyl-4-hydroxylase +)

98 ± 0.4

99.2 ± 0.4

Monocyte/macrophage (CD14+)

1.0 ± 0.5

0.95 ± 0.3

T-cells (CD3+)

0.5 ± 0.2

0.5 ± 0.1

B-cells (CD20+)

0.9 ± 0.1

0.8 ± 0.1


* Total number = five rheumatoid arthritis (RA) and five osteoarthritis (OA) patients. Monoclonal antibodies used for flow cytometry: mAb 5B5 1; mAb Tyk4 2; mAb UCHT-1 3; mAb B-Ly1 4. SEM = standard error of the mean; SF = synovial fluid.

Thwin et al. Arthritis Research & Therapy 2009 11:R138   doi:10.1186/ar2810

Open Data